Literature DB >> 32274072

We are all fighters.

Nanshan Zhong1.   

Abstract

Entities:  

Year:  2020        PMID: 32274072      PMCID: PMC7138990          DOI: 10.21037/jtd.2020.03.01

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   3.005


× No keyword cloud information.
The COVID-19 epidemic, which is attributed to a novel coronavirus of zoonotic origin (SARS-CoV-2), has endured for 3 months (1). Globally, over 80,000 people have been infected, with more than 3,000 resulting deaths. China has borne most of the disease burden, especially Hubei province, the epicenter of the outbreak. On January 23, 2020, China implemented strict measures in an effort to control the epidemic; these included a quarantine of the Greater Wuhan area, the extension of national holidays, and rigorous monitoring of civilian activities. These interventions have effectively restricted population migration and movement and have caused significant social, economic, and psychological disruption across the country. It is imperative to know if these measures have proved effective and for how long they should remain in place. Owing to the unprecedented nature of this outbreak and the control measures implemented, modelling studies are useful to simulate and predict epidemic trends under a desired scenario. The epidemic occurred just before the 2020 Spring Festival in Wuhan, one of China’s busiest transportation hubs. As a result, the population’s migratory activity is fundamental in trying to understand the spread and progression of this epidemic. One of the earliest studies to incorporate migration data to predict the spread of the epidemic was produced by a team from The University of Hong Kong (2). Using exported COVID-19 cases and migration data from Wuhan, they inferred the epidemic breakout size and predicted the outward spread of the disease to other major cities. Importantly, their model predicted that Wuhan-sized outbreaks would occur in other major Chinese cities if control measures were not put in place. However, their study used data only up to January 21, and was in no way able to account for the impact of the control measures implemented on January 23. The impact of the control measures is reflected in the current epidemic situation. Although Hubei, and in particular Wuhan, is still suffering disproportionately, outbreaks in other cities have largely been brought under control, with cases outside of Hubei accounting for only 20% of the total number reported nationally. In this issue of Journal of Thoracic Disease (JTD) (3), Yang et al., attempted to provide a prediction of the epidemic trends based on the current situation in China (i.e., after the implementation of control measures). They used a dynamic Susceptible-Exposed-Infectious-Recovered model incorporating the population migration data before and after January 23 to reflect the impact of the national intervention. Based on our more recent understanding of the virus’s transmissibility, they included a key assumption: that the disease is transmissible during the incubation period, which is a key difference between SARS-CoV-2 and SARS-CoV. Their model also accounts for the reduced contact rate resulting from quarantining and social-distancing measures. As China is currently experiencing a downward trend in new COVID-19 infections, we are able to see that their prediction so far has fairly accurate. The epidemic peak time and size predicted by their model have closely reflected the current actual reported data, particularly for Guangdong and Zhejiang. The situation in Hubei has been complicated by the change in the reporting process. Even so, Yang et al.’s prediction still remains within reasonable range of the actual situation. Importantly, their model predicted that we are on a downward trend and, with the exception of Hubei, the epidemic should settle down by the end of April. This observation was supported by their use of an artificial-intelligence (AI) machine learning-based prediction. In any modelling study, accurate epidemiological data and assumptions are critical. Early understanding of an epidemic progression is important for timely intervention, but model predictions are less robust due to the lack of solid epidemiological data. Perhaps the use of AI technology, which can take past experiences into account, can be harnessed to overcome this pitfall and improve our response to outbreaks in the future.
  3 in total

1.  Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study.

Authors:  Joseph T Wu; Kathy Leung; Gabriel M Leung
Journal:  Lancet       Date:  2020-01-31       Impact factor: 79.321

2.  Clinical Characteristics of Coronavirus Disease 2019 in China.

Authors:  Wei-Jie Guan; Zheng-Yi Ni; Yu Hu; Wen-Hua Liang; Chun-Quan Ou; Jian-Xing He; Lei Liu; Hong Shan; Chun-Liang Lei; David S C Hui; Bin Du; Lan-Juan Li; Guang Zeng; Kwok-Yung Yuen; Ru-Chong Chen; Chun-Li Tang; Tao Wang; Ping-Yan Chen; Jie Xiang; Shi-Yue Li; Jin-Lin Wang; Zi-Jing Liang; Yi-Xiang Peng; Li Wei; Yong Liu; Ya-Hua Hu; Peng Peng; Jian-Ming Wang; Ji-Yang Liu; Zhong Chen; Gang Li; Zhi-Jian Zheng; Shao-Qin Qiu; Jie Luo; Chang-Jiang Ye; Shao-Yong Zhu; Nan-Shan Zhong
Journal:  N Engl J Med       Date:  2020-02-28       Impact factor: 91.245

3.  Modified SEIR and AI prediction of the epidemics trend of COVID-19 in China under public health interventions.

Authors:  Zifeng Yang; Zhiqi Zeng; Ke Wang; Sook-San Wong; Wenhua Liang; Mark Zanin; Peng Liu; Xudong Cao; Zhongqiang Gao; Zhitong Mai; Jingyi Liang; Xiaoqing Liu; Shiyue Li; Yimin Li; Feng Ye; Weijie Guan; Yifan Yang; Fei Li; Shengmei Luo; Yuqi Xie; Bin Liu; Zhoulang Wang; Shaobo Zhang; Yaonan Wang; Nanshan Zhong; Jianxing He
Journal:  J Thorac Dis       Date:  2020-03       Impact factor: 3.005

  3 in total
  1 in total

1.  Forecasting of COVID-19: transmission models and beyond.

Authors:  Yang Zhao; Yongyue Wei; Feng Chen
Journal:  J Thorac Dis       Date:  2020-05       Impact factor: 3.005

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.